[1]管丹丹,陈溢滢,陈昊天,等.“从督论治” 针刺治疗颈椎病合并高血压病临床研究[J].陕西中医,2022,(5):648-652.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.025]
　GUAN Dandan,CHEN Yiying,CHEN Haotian,et al.Clinical study on acupuncture from dumeridian in treating hypertension complicated with cervical spondylosis[J].,2022,(5):648-652.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.025]
点击复制

“从督论治” 针刺治疗颈椎病合并高血压病临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年5期
页码:
648-652
栏目:
针灸经络
出版日期:
2022-05-05

文章信息/Info

Title:
Clinical study on acupuncture from dumeridian in treating hypertension complicated with cervical spondylosis
作者:
管丹丹1; 陈溢滢1; 陈昊天1; 崔萌珺1; 刘 聪1; 陈 理2
(1.南京中医药大学附属医院,江苏 南京 210029; 2.江苏省中医院,江苏 南京 210029)
Author(s):
GUAN Dandan; CHEN Yiying; CHEN Haotian; CUI Mengjun; LIU Cong; CHEN Li
(Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210029,China)
关键词:
高血压病;  颈椎病;  针刺;  督脉;  苯磺酸氨氯地平片;  血管内皮功能
Keywords:
Hypertension;  Cervical spondylosis;  Acupuncture;  Dumeridian;  Amlodipine besylate tablets;  Vessel endothelial function
分类号:
R 544.1
DOI:
DOI:10.3969/j.issn.1000-7369.2022.05.025
文献标志码:
A
摘要:
目的:观察针刺“从督论治”颈椎病合并高血压患者的临床疗效。 方法:选取颈椎病合并高血压患者60例,按照随机数字表法分为针刺组和对照组,对照组采用常规西医对症降压治疗,针刺组在对照组基础上采用针刺“从督论治”取穴治疗,两组均治疗4周。观察两组患者治疗前后血压、颈椎病躯体症状及血管内皮功能改善情况。结果: 两组患者治疗前收缩压(SBP)、舒张压(DBP)、中医证候积分、血清肿瘤坏死因子(TNF-α)、内皮素-1(ET-1)、一氧化氮(NO)比较差异无统计学意义(P>0.05)。治疗后两组患者SBP、DBP均有不同程度下降,针刺组优于对照组(P<0.05); 并且针刺组在颈椎病躯体症状改善起效时间上更短(P<0.05),对患者颈椎功能改善作用更显著(P<0.05)。治疗后两组血清TNF-α、ET-1都较前下降(P<0.05),NO较前升高(P<0.05),针刺组TNF-α、ET-1较对照组更低(P<0.05),NO高于对照组(P<0.05)。两组治疗过程中未出现严重不良反应,针刺组治疗效果较对照组更好(P<0.05)。结论:针刺“从督论治”颈椎病合并高血压患者具有较好的降压效果,并且能够降低炎症反应,改善血管内皮功能,安全性更高。
Abstract:
Objective:To investigate the clinical efficacy of acupuncture from dumeridian in hypertensive patients complicated with cervical spondylosis.Methods:A total of 60 patients with hypertension complicated with cervical spondylosis and divided into acupuncture group and control group according to random number method.The control group received conventional medicine treatment,and the acupuncture group was treated with acupuncture from dumeridian based on the control group.Both groups were treated for 4 weeks.Blood pressure,somatic symptoms of cervical spondylosis and improvement of vascular endothelial function in 2 groups were observed before and after treatment.Results:Before treatment,there were no significant differences between 2 groups in systolic blood pressure(SBP),diastolic blood pressure(DBP),TCM syndrome score,serum tumor necrosis factor(TNF-α),endothelin-1(ET-1)and nitric oxide(NO)(P>0.05).After treatment,both of SBP and DBP in 2 groups decreased to different degrees,and acupuncture group was better than control group(P<0.05).Moreover,acupuncture group had shorter time in improving the physical symptoms of cervical spondylosis(P<0.05),and more significant effect on the improvement of cervical vertebra function(P<0.05).After treatment,serum TNF-α and ET-1 in both groups were decreased(P<0.05),and NO was increased(P<0.05).In acupuncture group,serum TNF-α and ET-1 were lower than that in control group(P<0.05),and NO was higher than that in control group(P<0.05).There were no serious adverse reactions in the two groups,and the therapeutic effect of acupuncture group was better than the control group(P<0.05).Conclusion:Acupuncture from dumeridian has better antihypertensive effect,and can reduce inflammatory response,improve vascular endothelial function,with higher safety.

参考文献/References:

[1] 马 静.颈椎病与内科心脑血管病的关系[J].世界最新医学信息文摘,2019,19(49):38-42.
[2] Perdomo PA,Chara A,Liu A,et al.Surgical decompression for cervical spondylotic myelopathy in patients with associated hypertension:A single-center retrospective cohort and systematic review of the literature[J].World Neurosurg,2021(155):119-130.
[3] Li P,Wei Z,Zhang H,et al.Effects of decompressive operation on cardiac autonomic regulation in patients with cervical spondylotic myelopathy:Analysis of blood pressure,heart rate,and heart rate variability[J].Eur Spine J,2019,28(8):1864-1871.
[4] 刘 军,李伟伟,弓立群,等.经前路钩突切除椎间融合术治疗失稳神经根型颈椎病疗效观察[J].陕西医学杂志,2017,46(11):1578-1580.
[5] 于 娟,赵晓平,范小璇,等.颈源性高血压病因病理研究进展[J].实用心脑肺血管病杂志,2021,29(1):128-133.
[6] 陈江红,冯 品,张 薇,等.贝那普利联合氨氯地平治疗老年高血压患者的安全性及有效性探讨[J].实用临床医药杂志,2020,24(18):71-73.
[7] Wang X,Ju J,Xu H.Nondrug therapies for hypertensive patients complicated with cervical spondylosis:A systematic review and meta-analysis[J].Medicine(Baltimore),2020,99(5):19006.
[8] 孙宁玲.《中国高血压防治指南(2018年修订版)》的重要修改及点评[J].中华心血管病杂志:网络版,2019,2(1):5.
[9] 李 雷.《颈椎病诊治与康复指南》解读[J].中国实用乡村医生杂志,2007,17(12):45-47.
[10] 沈 燕,卞凤丽,杨 芳,等.认知行为疗法对冠心病慢性心力衰竭患者治疗依从性及情绪的影响[J].当代护士:下旬刊,2021,28(1):50-52.
[11] 郭春霞,陈震霖.中医从心肝肾论治高血压病现代作用机制及优势探讨[J].陕西中医,2020,41(5):650-652.
[12] 杨 倩,张 媛,毕宇峰.从阳论治颈椎病研究进展[J].陕西中医,2020,41(5):690-692.
[13] 周红海,田 聪,陆 延.督脉与脊柱相关理论关系的辨析[J].中国全科医学,2016,19(16):1972-1975.
[14] 贾松涛,武佐元,乔兆辉,等.调督理筋针法治疗腰椎间盘突出症疗效观察[J].现代中西医结合杂志,2021,30(27):3034-3037.
[15] 王元新,薛爱荣,徐 鹏,等.醒脑开窍针法联合督脉灸治疗脊髓型颈椎病40例[J].中医研究,2021,34(4):30-32.
[16] 王嘉乐.通阳针法结合督脉贴治疗强直性脊柱炎(寒湿痹阻型)的临床观察[D].吉林:长春中医药大学,2019.
[17] 侯贵书,李 华,张 彤,等.北京某高校2016至2020年研究生新生血压和血尿酸变化[J].中国学校卫生,2021,42(10):1552-1554,1559.
[18] 刘建航,韦贵康,徐志为,等.韦贵康教授“六不通论”和“六通论”诊治颈源性血压异常的临证经验[J].中国全科医学,2016,19(16):1972-1975.
[19] 杨芳洁,吴大伟,何 坚.基于NLRP3炎性小体探讨芍药甘草汤对神经根型颈椎病大鼠的抗炎镇痛机制[J].福建中医药,2021,52(5):53-54.
[20] 潘伟东,陈志标,罗卫平,等.针刺联合推拿治疗瘀血阻络型椎动脉型颈椎病的临床观察[J].广州中医药大学学报,2021,38(9):1886-1893.
[21] 吕玲春,沈珈谊,韦铁民.高血压与微循环障碍相关性的研究进展[J].温州医科大学学报,2021,51(11):933-937.
[22] 欧阳雅蓉,傅为武,黄彩依,等.自噬在高血压靶器官损害中的作用及中医药治疗研究进展[J].陕西中医,2020,41(11):1669-1672.
[23] 闫 冬,陈 聪,宋咏梅.大椎穴治疗颈椎病的研究进展[J].山东中医杂志,2018,37(3):262-266.
[24] 肖家顺,白丰淇,冯国湘.《针灸大成》中风池穴的临床应用探析[J].实用中医内科杂志,2021,35(12):31-33.
[25] 王爱成,李 柏,赵永烈,等.风池穴的径路解剖与作用机理[J].中医研究,2010,23(1):68-70.
[26] 黄雯雯.深刺颈夹脊及风池穴对颈性眩晕患者颈动脉彩超血液流速改变影响的临床研究[J].中外医学研究,2021,19(8):73-75.
[27] 张凌凌,戈 盾.半夏白术天麻汤联合隔药灸治疗痰湿壅盛型原发性高血压的临床疗效及对血管内皮损伤标志物和早期肾损伤指标的影响[J].河北中医,2021,43(5):751-755.
[28] 丁阿凤,马莉莉,胡小露.卡托普利对高血压大鼠炎性因子的影响及与心室肥厚的相关性研究[J].陕西医学杂志,2019,48(10):1255-1257.
[29] 刘思洋,苏 彬,吴建龙,等.高血压脑出血患者血清TNF-α、IL-6及VEGF的表达及意义[J].河北医学,2021,27(9):1460-1464.

相似文献/References:

[1]董炎红,慕珂珂,李 琰,等.血清同型半胱氨酸与高血压病不同中医证型的相关性研究[J].陕西中医,2019,(4):453.
　DONG YanHong,MU Keke,LI Yan,et al.Research the correlation of serum homocysteine with different TCM syndromes of hypertension[J].,2019,(5):453.
[2]李 冀,王托资,付 强.从“辰酉时”辨治高血压病探析[J].陕西中医,2022,(3):338.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.016]
　LI Ji,WANG Tuozi,FU Qiang.Study on the theory of treating hypertension from “Chenyou Shi”[J].,2022,(5):338.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.016]
[3]孙国星,范 虹,高晶晶,等.长安雷氏心病痰瘀流派“痰瘀毒风”理论辨治高血压病[J].陕西中医,2022,(12):1787.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.034]
[4]刘孟珍,潘秋旭,韦 斌.名中医方显明从少阳论治高血压病经验[J].陕西中医,2023,(12):1783.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.026]
　LIU Mengzhen,PAN Qiuxu,WEI Bin.Professor Fang Xianming's clinical experience in treating hypertension from Shaoyang[J].,2023,(5):1783.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.026]
[5]李 楠,王埝琦,周德颖,等.名中医杜武勋基于“五脏生克制化”治疗高血压病经验[J].陕西中医,2025,46(3):390.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.022]
　LI Nan,WANG Nianqi,ZHOU Deying,et al.Famous Chinese medicine doctor DU Wuxun's experience in treating hypertension based on five internal organs generation and restraint[J].,2025,46(5):390.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.022]

备注/Memo

备注/Memo:
基金项目:江苏省中医药管理局科研项目(YB201817); 江苏省研究生科研创新计划项目(KYCX21_1671)
更新日期/Last Update: 2022-05-09